Relationship between serum adiponectin level and metabolic indices in patients with chronic hepatitis B
-
摘要:
目的探讨慢性乙型肝炎(CHB)和CHB合并脂肪肝患者血清脂联素(ADP)变化及与体脂、血脂、胰岛素抵抗(IR)的关系。方法选择CHB和CHB合并脂肪肝患者各20例,健康对照组18例,3组年龄、性别比较差异无统计学意义。测量其空腹体质量、腰围(WC)和臀围,检测血清胰岛素(FINS)、糖(FBG)、血脂和ALT、AST等,计算身体质量指数(BMI)、腰臀比(WHR)和胰岛素抵抗指数(HOMA-IR);采用ELISA法测定血清ADP浓度。计量资料采用均数±标准差(x±s)表示,组间比较采用单因素方差分析,计数资料组间比较采用卡方检验,相关性分析用Pearson相关分析。结果 CHB患者ADP质量浓度为(10.56±2.48)mg/L,CHB合并脂肪肝患者为(4.46±2.16)mg/L,对照组为(6.38±2.91)mg/L,3组差异有统计学意义(F=30.537,P=0.000)。CHB合并脂肪肝患者的BMI、WC、WHR及血清三酰甘油(TG)均明显高于CHB组和对照组(P均<0.01);3组血清FINS、FBG、胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇...
Abstract:Objective To investigate the relationship of serum adiponectin level with body fat, blood lipids, and insulin resistance (IR) in the patients with chronic hepatitis B (CHB) and patients with CHB and fatty liver.Methods Twenty patients CHB, 20 cases of CHB with fatty liver, and 18 healthy controls were included in the study;there were no significant differences in sex and age between the three groups.Fasting body weight, waist circumference (WC) , hip circumference (HC) , fasting insulin (FINS) , fasting blood glucose (FBG) , total cholesterol (TC) , triglyceride (TG) , high- density lipoprotein cholesterol (HDL- C) , low- density lipoprotein cholesterol (LDL- C) , alanine aminotransferase (ALT) , and aspartate aminotransferase (AST) were measured, and body mass index (BMI) , waist- to- hip ratio (WHR) , and homeostasis model assessment of insulin resistance were calculated.Serum concentrations of adiponectin were determined by enzyme- linked immunosorbent assay.Continuous data was expressed as x ± s, and comparisons between groups were made by one- way analysis of variance;comparisons of categorical data between groups were made by R × C χ2test;correlation analysis was performed by Pearson correlation test.Results The serum adiponectin concentrations of patients with CHB, patients with CHB and fatty liver, and healthy controls were 10.56 ± 2.48, 4.46 ± 2.16, and 6.38 ± 2.91 mg / L, respectively, with significant differences between the three groups (F = 30.537, P = 0.000) .The patients with CHB and fatty liver had significantly higher BMI, WC, WHR, and serum TG level than the CHB patients and healthy controls (P < 0.01) ;there were no significant differences in serum FINS, FBG, TC, HDL- C, LDL- C, and IR values between the three groups.Serum adiponectin level was only negatively correlated with TG in patients with CHB and fatty liver (r =- 0.485, P = 0.015) , but not correlated with BMI, WC, WHR, IR, FINS, FBG, TC, HDL- C, and LDL- C in all patients with CHB.Conclusion Serum adiponectin level significantly increases in the patients with CHB, which may presumably be the result of adiponectin exerting a protective effect on the liver, while it significantly decreases in the patients with CHB and fatty liver, which is closely related to elevated TG.
-
Key words:
- hepatitis B, chronic /
- fatty liver /
- adiponectin
-
[1]HUANG YL.Clinical significance of serum levels of adiponectin in patients with chronic hepatitis B[J].China Med Herald, 2012, 9 (27) :60-61. (in Chinese) 黄元亮.慢性乙型肝炎患者血清脂联素水平及其临床意义[J].中国医药导报, 2012, 9 (27) :60-61. [2] Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B (2010 version) [J].J Clin Hepatol, 2011, 27 (1) :Ⅰ-ⅩⅥ. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南 (2010年版) [J].临床肝胆病杂志, 2011, 27 (1) :Ⅰ-ⅩⅥ. [3]Fatty Liver and Alcoholic Liver Disease Study Group of Chinese Society of Hepatology.The guideline of diagnosis and treatment for non-alcoholic fatty liver disease (2010 version) [J].J Clin Hepatol, 2010, 26 (2) :120-124. (in Chinese) 中华医学会肝病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J].临床肝胆病杂志, 2010, 26 (2) :120-124. [4]WAN CY, LIU F, FU ZW.The progress in research on the physiological and pathophysiological role of adiponectin[J].Chin J Cell Biol, 2009, 31 (2) :163-168. (in Chinese) 万春燕, 刘芬, 傅正伟.脂联素的病理生理学研究进展[J].细胞生物学杂志, 2009, 31 (2) :163-168. [5]ZHAO CY, KONG LB, LI Y, et al.Expression and significance of adiponectin in liver of patients with nonalcoholic fatty liver disease[J].J Hebei Med, 2010, 32 (5) :522-525. (in Chinese) 赵彩彦, 孔令波, 李亚, 等.非酒精性脂肪性肝病患者肝组织脂联素表达及其意义[J].河北医药, 2010, 32 (5) :522-525. [6]CHEN YT, MA Y, DING TL, et al.The relationship of peripheral blood T cell subsets, serum of tumor necrosis factorαand intrahepatic vascular lesion in patients with chronic hepatitis B[J].Chin J Health Lab Technol, 2011, 21 (10) :2379-2381. (in Chinese) 陈勇涛, 马勇, 丁体龙, 等.慢性乙型肝炎患者外周血TNF-α及T细胞亚群与肝血管病变关系[J].中国卫生检验杂志, 2011, 21 (10) :2379-2381. [7]XU A, WANG Y, KESHAW H, et al.The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice[J].Clin Invest, 2003, 112:91-100. [8]LOUTHAN MV, BARVE S, MCCLAIN CJ, et al.Decreased serum adiponectin:an early event in pediatric non-alcoholic fatty liver disease[J].Pediat, 2005, 147 (6) :835-838. [9]LONG J, LIN SD, SU Y, et al.Serum levels of adiponectin in patients with chronic hepatitis B virus infection are decreased and associated with hepatic fibrosis and inflammation progression[J].Chin J Modern Med, 2011, 21 (20) :2392-2395. (in Chinese) 龙骏, 林世德, 苏毅, 等.慢性乙型肝炎患者血清脂联素水平与肝纤维化、炎症程度的相关性研究[J].中国现代医学杂志, 2011, 21 (20) :2392-2395. [10]ALTLPARMAK E, KOKLU S, YALINKILICM, et al.Viral and host causes of fatty liver in chronic hepatitis B[J].World J Gastroenterol, 2005, 11 (20) :3056-3059. [11]KOWALSKA I, STRACZKOWSKI M, NIKOLAJUK A, et al.Insulin resistance, serum adiponectin, and proinflammatory markers in young subjects with the metabolic syndrome[J].Metabolism, 2008, 57:1539-1544. [12]TANIGUCHI A, FUKUSHIMA M, OHYA M, et al.Interleukin6, adiponectin, leptin, and insulin resistance in nonobese Japanese type 2 diabetic patients[J].Metabolism, 2006, 55 (2) :258-262. [13]HUI JM, HODGE A, FARRELL GC, et al.Beyond insulin resistance in NASH:TNF-alpha or adiponectin?[J].Hepatology, 2004, 40 (1) :46-54.
计量
- 文章访问数: 2607
- HTML全文浏览量: 10
- PDF下载量: 588
- 被引次数: 0